N. Haghighat et Dw. Mccandless, EFFECT OF 6-AMINONICOTINAMIDE ON METABOLISM OF ASTROCYTES AND C6-GLIOMA CELLS, Metabolic brain disease, 12(1), 1997, pp. 29-45
Brain tissue cells have been shown to use two predominant pathways for
energy production. The first of these is the pentose phosphate shunt,
and the second is glycolysis, followed by the TCA cycle. Inhibition o
f these pathways can result in a reduction of ATP, and changes in the
concentration of various metabolites. In the present study, the acute
and chronic effect of 6-aminonicotinamide (6-AN) (0.01, 0.02, and 0.03
mg/ml) was examined on astrocytes and C6-glioma cells. Following this
treatment, glucose, lactate, glutamate, ATP, and PCr were assayed acc
ording to the procedures of Lowry and Passonneau. Our data indicated t
hat following 15 minutes treatment of astrocytes and C6-glioma with 6A
N there was no significant difference in the concentration of metaboli
tes measured. However, following 24 hours treatment there was a signif
icant increase in glucose concentration and significant reduction in t
he concentration of ATP, PCr, lactate and glutamate in both cell types
. Morphological changes appeared later following 48 hours treatment wi
th 6-AN in both cell types. Glucose accumulation can be explained by t
he fact that it is the precursor to both glycolysis and the pentose ph
osphate shunt. If these processes are inhibited, glucose will obviousl
y accumulate and products like ATP, PCr, lactate and glutamate will de
crease. Additionally, there was significant differences in concentrati
on of glucose and lactate between astrocytes and C6-glioma cells. The
significance of these differences has been discussed.